Atherosclerosis: Cell biology and lipoproteins - Oxidative stress and paraoxonases regulate atherogenesis

Current Opinion in Lipidology

Volumn 21, Issue 2, 2010, Pages 163-164

  Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; GLYCYRRHIZA EXTRACT; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; POLYCYSTIN 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE EXPRESSION; GLYCYRRHIZA; HUMAN; INSULIN RESISTANCE; MACROPHAGE; MONOCYTE; NONHUMAN; NOTE; OXIDATIVE STRESS; POMEGRANATE JUICE; PRIORITY JOURNAL; RED WINE; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; EDITORIAL; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; HUMANS; LIPOPROTEINS; OXIDATIVE STRESS;

EID: 77957355207     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283376936     Document Type: Note

References (10)

1. Rosenblat M, Aviram M. Paraoxonases role in the prevention of cardiovascular diseases. BioFactors 2009; 35:98-104.
2. Cubbon RM, Kahn MB, Wheatcroft SB. Effects of insulin resistance on endothelial progrenitor cells and vascular repair. Clin Sci 2009; 117:173-190.
3. Fuhrman B, Volkova N, Aviram M. Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patients. Nutrition 2010 (in press).
4. Khatteb J, Gantman A, Kreitenberg AJ, et al. Paraoxonase 1 (PON 1) expression in hepatocytes is upregulated by pomegranate polyphenols: a expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. Atherosclerosis 2010 (in press).
5. Tan M, Hao F, Xu X, et al. Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration. Arterioscler Thromb Vasc Biol 2009; 29:1376-1382.
6. Khakpour H, Frishman WH. Lipoprotein-associated phospholipase A(2) an independent predictor of cardiovascular risk and novel target for immuno-modulation therapy. Cardiol Rev 2009; 17:222-229.
7. Vickers KC, Maguire CT, Wolfert R, et al. Relationship of lipoprotein-asso-ciated phospholipase A(2) and oxidized low density lipoprotein in carotid atherosclerosis. J Lipid Res 2009; 50:1735-1743.
8. Tavori H, Aviram M, Khatib S, et al. Human carotid atherosclerotic plaque increases oxidation state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med 2009; 46:607-615.
9. Ikeda Y, Inoue M, Suehiro T, et al. Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes. Acta Diabetol 2009; 46:239-242.
10. Younis N, Soran H, Sharma R, et al. glycation of LDL is an important atherogenic modification and opposed by paraoxonase-rich HDL. Atherosclerosis 2009; 207:306.